🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the optimal use, efficacy, and safety of a Trea...
Status
Completed
Location
Multiple Locations
Start Date
2015-11-19
Trial ID
NCT02581891
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2014-12-08
Trial ID
NCT02307682
Treatments Being Tested
Regeneron Pharmaceuticals developed a single-dose pre-filled syringe (PFS) ...
Status
Completed
Location
Retina Consultants of Texas
Start Date
2024-04-15
Trial ID
NCT05989126
Treatments Being Tested
The study is designed for multi-center,randomized,double-masked,active-cont...
Status
Active Not Recruiting
Location
Shanghai General Hospital
Start Date
2023-09-21
Trial ID
NCT05972473
Treatments Being Tested
Oculgen has begun a study of an investigational drug called OCUL101 as a po...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-17
Trial ID
NCT07520318
Treatments Being Tested
To determine the efficacy of intravitreally (IVT) administered VEGF Trap-Ey...
Status
Completed
Location
Multiple Locations
Start Date
2013-02
Trial ID
NCT01783886
This is a multi-center, randomized, double-masked, active-comparator-contro...
Status
Recruiting
Location
Adverum Clinical Site 245
Start Date
2026-03-16
Trial ID
NCT07482176
Treatments Being Tested
This study is a randomized, prospective, exploratory, descriptive, open lab...
Status
Unknown
Location
GOGIUNTA
Start Date
2019-07-24
Trial ID
NCT04113538
Treatments Being Tested
The primary objective of the study is to compare the efficacy of intravitre...
Status
Completed
Location
Regeneron Investigational Site
Start Date
2016-03-31
Trial ID
NCT02713204
Treatments Being Tested
This Phase 3 study will evaluate the efficacy, durability, and safety of KS...
Status
Terminated
Location
UCSD Jacobs Retina Center
Start Date
2020-09-30
Trial ID
NCT04611152
Treatments Being Tested